Dupilumab Treatment is Not Associated with Increased Risk of Overall Skin Infections [Letter]
| Autor: | Wiggins S, Levit NA |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2023 |
| Předmět: | |
| Zdroj: | ImmunoTargets and Therapy, Vol Volume 12, Pp 77-78 (2023) |
| Druh dokumentu: | article |
| ISSN: | 2253-1556 |
| Popis: | Simmi Wiggins,1,* Noah A Levit2,* 1Sanofi, 410 Thames Valley Park Dr, Reading, RG6 1PT, UK; 2Regeneron Pharmaceuticals Inc, Tarrytown, NY, 10591, USA*These authors contributed equally to this workCorrespondence: Simmi Wiggins, Sanofi, 410 Thames Valley Park Dr, Reading, RG6 1PT, UK, Tel +44 (0) 1183 543 000, Fax +44 (0) 800 471 8627, Email Simmi.Wiggins@sanofi.com |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|